PTX3 and COVID-19: A meta-analysis by Capra et al., which included 12 clinical studies evaluating PTX3 plasma levels in COVID-19 patients, demonstrated that high PTX3 levels are indicative of severe COVID-19 and correlate with poor outcomes [26].